Eton Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $10.7M | $26.3M | $21.3M |
| FY2021 | $9.8M | $27.5M | $14.4M |
| FY2022 | $12.0M | $25.0M | $16.3M |
| FY2023 | $16.3M | $31.7M | $21.4M |
| FY2024 | $51.7M | $76.1M | $14.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $10.7M | $26.3M | $21.3M |
| FY2021 | $9.8M | $27.5M | $14.4M |
| FY2022 | $12.0M | $25.0M | $16.3M |
| FY2023 | $16.3M | $31.7M | $21.4M |
| FY2024 | $51.7M | $76.1M | $14.9M |